Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) PE Ratio (TTM): 13.24 (As of Jul. 27, 2026) — 72% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
81 GF Score
Price ¥43.83
GF Value ¥67.47
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co PE Ratio (TTM)?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 +2.65% 81 PE Ratio (TTM) is 13.24 as of Jul. 27, 2026, which is 72% below its 10-year median of 47.65. GuruFocus rates SHSE:688336 with a GF Score™ of 81/100 and a GF Value™ of ¥67.47 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 270 Biotechnology companies, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks better than 73.33% on this metric.

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-27), Sunshine Guojian Pharmaceutical (Shanghai) Co's share price is ¥43.83. Sunshine Guojian Pharmaceutical (Shanghai) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3.31. Therefore, Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) for today is 13.24.


The historical rank and industry rank for Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) or its related term are showing as below:

SHSE:688336' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 11.5   Med: 47.65   Max: 703.45
Current: 13.24


During the past 13 years, the highest PE Ratio (TTM) of Sunshine Guojian Pharmaceutical (Shanghai) Co was 703.45. The lowest was 11.50. And the median was 47.65.


SHSE:688336's PE Ratio (TTM) is ranked better than
73.33% of 270 companies
in the Biotechnology industry
Industry Median: 26.94 vs SHSE:688336: 13.24

Sunshine Guojian Pharmaceutical (Shanghai) Co's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was ¥0.20. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3.31.

As of today (2026-07-27), Sunshine Guojian Pharmaceutical (Shanghai) Co's share price is ¥43.83. Sunshine Guojian Pharmaceutical (Shanghai) Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3.25. Therefore, Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio without NRI for today is 13.48.

During the past 13 years, Sunshine Guojian Pharmaceutical (Shanghai) Co's highest PE Ratio without NRI was 1145.40. The lowest was 11.70. And the median was 58.20.

Sunshine Guojian Pharmaceutical (Shanghai) Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.18. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3.25.

During the past 12 months, Sunshine Guojian Pharmaceutical (Shanghai) Co's average EPS without NRI Growth Rate was 323.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 349.30% per year.

During the past 13 years, Sunshine Guojian Pharmaceutical (Shanghai) Co's highest 3-Year average EPS without NRI Growth Rate was 349.30% per year. The lowest was -49.60% per year. And the median was 16.60% per year.

Sunshine Guojian Pharmaceutical (Shanghai) Co's EPS (Basic) for the three months ended in Mar. 2026 was ¥0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3.32.


Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Sunshine Guojian Pharmaceutical (Shanghai) Co PE Ratio (TTM) Related Terms


Sunshine Guojian Pharmaceutical (Shanghai) Co PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co PE Ratio (TTM) Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 609.20 159.25 46.90 18.79 12.73

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.12 43.75 40.57 12.73 15.74

SHSE:688336 vs VRTX, REGN, RVMD: PE Ratio (TTM) Comparison

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Guojian Pharmaceutical (Shanghai) Co PE Ratio (TTM) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) falls into.


SHSE:688336
81GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
PE Ratio (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=43.83/3.311
=13.24

Sunshine Guojian Pharmaceutical (Shanghai) Co's Share Price of today is ¥43.83.
Sunshine Guojian Pharmaceutical (Shanghai) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio (TTM) →
What does a PE Ratio (TTM) of 13.24 mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a PE Ratio (TTM) of 13.24 as of Jul. 27, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. This is 72% below median its historical median of 47.65. Over the past decade, Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) has ranged from 11.50 to 703.45. According to the industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #72 out of 270 companies in the Biotechnology industry, placing it in the top 26.7%.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current PE Ratio (TTM) of 13.24 is 72% below median its 10-year median of 47.65. Over the past 10 years, this metric has ranged from a low of 11.50 to a high of 703.45. The Biotechnology industry median PE Ratio (TTM) is 26.94. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 13.24 is 50.9% below this industry median. Based on the distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #72 out of 270 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's PE Ratio (TTM) compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #72 out of 270 companies for PE Ratio (TTM). This puts Sunshine Guojian Pharmaceutical (Shanghai) Co in the upper half of its industry. The industry median PE Ratio (TTM) is 26.94. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 13.24 is 50.9% below this benchmark. Historically, Sunshine Guojian Pharmaceutical (Shanghai) Co's own PE Ratio (TTM) has ranged from 11.50 to 703.45 over the past decade. While the company's 10-year median is 47.65 vs. the industry median of 26.94, Sunshine Guojian Pharmaceutical (Shanghai) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Biotechnology company?
The median PE Ratio (TTM) among Biotechnology companies is 26.94, based on 270 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Guojian Pharmaceutical (Shanghai) Co's current PE Ratio (TTM) of 13.24 is 50.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. For the Biotechnology industry, the median PE Ratio (TTM) is 26.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Guojian Pharmaceutical (Shanghai) Co's current PE Ratio (TTM) is 13.24, which is 72% below median its own 10-year median of 47.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Possible Value Trap. The stock's GF Value™ is ¥67.47, compared to a current price of ¥43.83 — trading 35% below its estimated fair value. The current PE Ratio (TTM) is 13.24, which is 72% below median its 10-year median of 47.65 and 50.9% below the Biotechnology industry median of 26.94. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current PE Ratio (TTM) is 13.24 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥43.83 is trading 35% below its estimated GF Value™ of ¥67.47. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Possible Value Trap.

Key valuation signals for SHSE:688336:

  • PE Ratio (TTM): 13.24 (72% below median its 10-year median of 47.65)
  • GF Value™: ¥67.47 vs. price of ¥43.83 (35% below fair value)
  • GF Score™: 81/100 with 3 warning signs
  • Industry Position: 50.9% below the Biotechnology median (#72 of 270)

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
81GF Score

Get the complete analysis for SHSE:688336

PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥43.83
Price
¥67.47
GF Value